Paul G. Sleph

Role of myocardial ATP-sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine A1-receptors.

G. J. Grover, Paul G. Sleph, Steven Dzwonczyk · Circulation · 1992 · 258 citations · Full text

Pharmacologic Profile of the Dihydropyrimidine Calcium Channel Blockers SQ 32,547 and SQ 32,946

Gary J. Grover, Steven Dzwonczyk, Diane M. McMullen et al. · Journal of Cardiovascular Pharmacology · 1995 · 256 citations

Molecular Pharmacology, Cardiovascular Disease, Medicine +14

Selective thyroid hormone receptor-β activation: A strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability

Gary J. Grover, Karin Mellström, Ye Liu et al. · Proceedings of the National Academy of Sciences · 2003 · 222 citations · Full text

Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.

G. J. Grover, John R. McCullough, D E Henry et al. · Journal of Pharmacology and Experimental Therapeutics · 1989 · 177 citations

Effects of the Thyroid Hormone Receptor Agonist GC-1 on Metabolic Rate and Cholesterol in Rats and Primates: Selective Actions Relative to 3,5,3′-Triiodo-<scp>l</scp>-Thyronine

Gary J. Grover, Donald Egan, Paul G. Sleph et al. · Endocrinology · 2004 · 162 citations · Full text

Metabolic Rate, Obesity, Molecular Pharmacology +20